IVVD Stock Analysis: Buy, Sell, or Hold?
IVVD - Invivyd, Inc. Common Stock
$1.46
-0.05 (-3.31%)
▼
5d:
-16.09%
30d:
-6.41%
90d:
-30.81%
WAIT
LOW Confidence
Analysis Updated: Apr 24, 2026 12:00 AM ET
Earnings: May 21, 2026
25d
Smart Money Accumulation
IVVD is down 15.3% this week, but smart money is accumulating calls. Top strike: $1.5 2026-05-15 with 1 OI. Call ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When IVVD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: IVVD is down 16.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: IVVD is down 16.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: IVVD is currently trading at $1.46, which is considered fair relative to its 30-day fair value range of $1.35 to $1.68.
Technical Outlook: Technically, IVVD is in a strong downtrend. The price is currently testing key support at $1.42. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: IVVD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $10.00 (+584.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IVVD is in a strong downtrend. The price is currently testing key support at $1.42. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: IVVD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $10.00 (+584.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$1.35 -
$1.68
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
44.7%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.3%)
- BULLISH: Trading 584.9% below Wall St target ($10.00)
Fair Price Analysis
30-Day Fair Range
$1.35 -
$1.68
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$1.42
Resistance Level
$1.80
Current Trend
Strong Downtrend
Technical data as of
Apr 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.64
Wall Street Target
$10.00
(+584.9%)
Revenue Growth (YoY)
24.5%
Profit Margin
-98.2%
Share & Embed Analysis
Last updated: April 25, 2026 7:15 AM ET
Data refreshes hourly during market hours. Next update: 8:15 AM
Data refreshes hourly during market hours. Next update: 8:15 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IVVD showing a specific setup today?
Insider Activity (6 Months)
1
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Julie Green
SELL
20964 shares
2026-02-18
Robert D Allen III
SELL
19392 shares
2026-02-18
Timothy Edward Lee
SELL
20964 shares
2026-02-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 60 BUY |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1034 | 54 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$111 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 54 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$294 | 52 HOLD |
